Paper29045477
Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
Saito S and 7 others. PLoS One, 2017. Cited by 100 papers, by iCite.
Cite this record
ConductScience Library. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway. Papers, record 29045477. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29045477
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics34
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hydroxamic Acids | Major topic |
| Idiopathic Pulmonary Fibrosis | Major topic |
| Indoles | Major topic |
| Phosphatidylinositol 3-Kinases | Major topic |
| Proto-Oncogene Proteins c-akt | Major topic |
| Signal Transduction | Major topic |
| Transforming Growth Factor beta | Major topic |
| Aged | |
| Aged, 80 and over | |
| Animals | |
| Autophagosomes | |
| Autophagy | |
| Bleomycin | |
| Collagen Type I | |
| Female | |
| Fibroblasts | |
| Histone Deacetylase 6 | |
| Histone Deacetylases | |
| Humans | |
| Hypoxia-Inducible Factor 1, alpha Subunit | |
| Lung | |
| Male | |
| Mechanistic Target of Rapamycin Complex 1 | |
| Mice, Knockout | |
| Middle Aged | |
| Multiprotein Complexes | |
| Nuclear Proteins | |
| Phosphoprotein Phosphatases | |
| Phosphorylation | |
| RNA, Messenger | |
| Ribosomal Protein S6 Kinases | |
| TOR Serine-Threonine Kinases | |
| Tubulin | |
| Vascular Endothelial Growth Factor A |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| U54 GM104940 | NIGMS NIH HHS | United States | U54GM104940 | PubMed and NIH |
Source NIH RePORTER
References44
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26059457 | Deregulation of selective autophagy during aging and pulmonary fibrosis: the role of TGFβ1. | Aging Cell | 2015 | https://conductscience.org/library/papers/26059457 | PubMed |
| 2 | 22473468 | The functions and regulation of the PTEN tumour suppressor. | Nat Rev Mol Cell Biol | 2012 | https://conductscience.org/library/papers/22473468 | PubMed |
| 3 | 24603818 | Histone deacetylase inhibition promotes fibroblast apoptosis and ameliorates pulmonary fibrosis in mice. | Eur Respir J | 2014 | https://conductscience.org/library/papers/24603818 | PubMed |
| 4 | 24392697 | Turning off AKT: PHLPP as a drug target. | Annu Rev Pharmacol Toxicol | 2014 | https://conductscience.org/library/papers/24392697 | PubMed |
| 5 | 26763233 | Loss of α-Tubulin Acetylation Is Associated with TGF-β-induced Epithelial-Mesenchymal Transition. | J Biol Chem | 2016 | https://conductscience.org/library/papers/26763233 | PubMed |
| 6 | 24382387 | New and emerging HDAC inhibitors for cancer treatment. | J Clin Invest | 2014 | https://conductscience.org/library/papers/24382387 | PubMed |
| 7 | 11401831 | Phosphatidylinositol 3-kinase-dependent stabilization of alpha1(I) collagen mRNA in human lung fibroblasts. | Am J Physiol Cell Physiol | 2001 | https://conductscience.org/library/papers/11401831 | PubMed |
| 8 | 27103349 | Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF. | Thorax | 2016 | https://conductscience.org/library/papers/27103349 | PubMed |
| 9 | 24762191 | Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo. | Respir Res | 2014 | https://conductscience.org/library/papers/24762191 | PubMed |
| 10 | 26359372 | Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis. | Thorax | 2015 | https://conductscience.org/library/papers/26359372 | PubMed |
| 11 | 23526222 | Animal models of fibrotic lung disease. | Am J Respir Cell Mol Biol | 2013 | https://conductscience.org/library/papers/23526222 | PubMed |
| 12 | 21984893 | Inhibition of PI3K prevents the proliferation and differentiation of human lung fibroblasts into myofibroblasts: the role of class I P110 isoforms. | PLoS One | 2011 | https://conductscience.org/library/papers/21984893 | PubMed |
| 13 | 18499657 | Requirement of HDAC6 for transforming growth factor-beta1-induced epithelial-mesenchymal transition. | J Biol Chem | 2008 | https://conductscience.org/library/papers/18499657 | PubMed |
| 14 | 18503048 | Transforming growth factor-beta1 induces heparan sulfate 6-O-endosulfatase 1 expression in vitro and in vivo. | J Biol Chem | 2008 | https://conductscience.org/library/papers/18503048 | PubMed |
| 15 | 25689721 | Ursolic acid attenuates diabetic mesangial cell injury through the up-regulation of autophagy via miRNA-21/PTEN/Akt/mTOR suppression. | PLoS One | 2015 | https://conductscience.org/library/papers/25689721 | PubMed |
| 16 | 20719940 | Histone deacetylase: a potential therapeutic target for fibrotic disorders. | J Pharmacol Exp Ther | 2010 | https://conductscience.org/library/papers/20719940 | PubMed |
| 17 | 20614936 | Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A. | J Am Chem Soc | 2010 | https://conductscience.org/library/papers/20614936 | PubMed |
| 18 | 19520917 | Phosphatidylinositol-3-kinase/akt regulates bleomycin-induced fibroblast proliferation and collagen production. | Am J Respir Cell Mol Biol | 2010 | https://conductscience.org/library/papers/19520917 | PubMed |
| 19 | 24691964 | Erasers of histone acetylation: the histone deacetylase enzymes. | Cold Spring Harb Perspect Biol | 2014 | https://conductscience.org/library/papers/24691964 | PubMed |
| 20 | 11502094 | TNF-alpha, PDGF, and TGF-beta(1) expression by primary mouse bronchiolar-alveolar epithelial and mesenchymal cells: tnf-alpha induces TGF-beta(1). | Exp Mol Pathol | 2001 | https://conductscience.org/library/papers/11502094 | PubMed |
Cited by69
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 100 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42910219 | Histone acetyltransferases and deacetylase 6 (HDAC6) Promotes Hepatic Stellate Cell Activation and Liver Fibrosis. | Int J Biol Sci | 2026 | https://conductscience.org/library/papers/42910219 | PubMed |
| 42688556 | Pulmonary Hypertension Molecular Switch: HIF Signaling Pathway. | Pulm Circ | 2026 | https://conductscience.org/library/papers/42688556 | PubMed |
| 42063468 | Therapeutic potential of HDAC6 inhibitor Tubastatin A in health and diseases: current perspective and future directions. | Mil Med Res | 2026 | https://conductscience.org/library/papers/42063468 | PubMed |
| 41869495 | Epigenetic regulatory mechanisms and translational applications in idiopathic pulmonary fibrosis. | Am J Clin Exp Immunol | 2026 | https://conductscience.org/library/papers/41869495 | PubMed |
| 41588194 | Climate Change and the Impact On Interstitial Lung Diseases. | Pulm Ther | 2026 | https://conductscience.org/library/papers/41588194 | PubMed |
| 40843669 | Targeting the Kynureninase-HDAC6-Complement Axis as a Novel Therapeutic Strategy in Glioblastoma. | Epigenomes | 2025 | https://conductscience.org/library/papers/40843669 | PubMed |
| 40750768 | High-selective HDAC6 inhibitor alleviates bone marrow fibrosis through inhibiting collagen formation and extracellular matrix deposition. | Sci Rep | 2025 | https://conductscience.org/library/papers/40750768 | PubMed |
| 40635201 | Contribution of histone deacetylases (HDACs) to the regulation of histone and non-histone proteins: implications for fibrotic diseases. | BMB Rep | 2025 | https://conductscience.org/library/papers/40635201 | PubMed |
| 40615924 | The role of HDAC6 in fibrosis: a novel and effective therapy strategy. | Eur J Med Res | 2025 | https://conductscience.org/library/papers/40615924 | PubMed |
| 40585959 | Mesenchymal stem cells-derived exosomes alleviate radiation induced pulmonary fibrosis by inhibiting the protein kinase B/nuclear factor kappa B pathway. | World J Stem Cells | 2025 | https://conductscience.org/library/papers/40585959 | PubMed |
| 40310526 | Pentadecanoic acid attenuates thioacetamide-induced liver fibrosis by modulating oxidative stress, inflammation, and ferroptosis pathways in rat. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | https://conductscience.org/library/papers/40310526 | PubMed |
| 40140071 | Hepatic microtubule destabilization facilitates liver fibrosis in the mouse model of Wilson disease. | J Mol Med (Berl) | 2025 | https://conductscience.org/library/papers/40140071 | PubMed |
| 40070559 | The Mechanisms and Therapeutic Implications of PI3K Signaling in Airway Inflammation and Remodeling in Asthma. | Biologics | 2025 | https://conductscience.org/library/papers/40070559 | PubMed |
| 39974640 | Spirotetrahydroisoquinoline-Based Histone Deacetylase Inhibitors as New Antifibrotic Agents: Biological Evaluation in Human Fibroblasts from Bronchoalveolar Lavages of Idiopathic Pulmonary Fibrosis Patients. | ACS Pharmacol Transl Sci | 2025 | https://conductscience.org/library/papers/39974640 | PubMed |
| 39549058 | Identification of potential mechanisms of Schisandrin B in the treatment of idiopathic pulmonary fibrosis by integrating network pharmacology and experimental validation. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | https://conductscience.org/library/papers/39549058 | PubMed |
| 39544928 | Understanding the molecular regulatory mechanisms of autophagy in lung disease pathogenesis. | Front Immunol | 2024 | https://conductscience.org/library/papers/39544928 | PubMed |
| 39422111 | Histone deacetylase 6 inhibition promotes microtubule acetylation and facilitates autophagosome-lysosome fusion in dystrophin-deficient mdx mice. | Acta Physiol (Oxf) | 2025 | https://conductscience.org/library/papers/39422111 | PubMed |
| 39329199 | Therapeutic role of histone deacetylase inhibition in an in vitro model of Graves' orbitopathy. | Mol Med Rep | 2024 | https://conductscience.org/library/papers/39329199 | PubMed |
| 39280777 | Resveratrol reinforces the therapeutic effect of mesenchymal stem cell (MSC)-derived exosomes against renal ischemia‒reperfusion injury (RIRI)-associated fibrosis by suppressing TGF-β-induced epithelial-mesenchymal transition. | Int J Cardiol Cardiovasc Risk Prev | 2024 | https://conductscience.org/library/papers/39280777 | PubMed |
| 39224841 | BRD3308 suppresses macrophage oxidative stress and pyroptosis via upregulating acetylation of H3K27 in sepsis-induced acute lung injury. | Burns Trauma | 2024 | https://conductscience.org/library/papers/39224841 | PubMed |
Genes18
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29045477
GET https://conductscience.org/api/papers/v1/29045477/references?page=2